6DWF image
Deposition Date 2018-06-26
Release Date 2019-01-30
Last Version Date 2024-10-16
Entry Detail
PDB ID:
6DWF
Keywords:
Title:
Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.94 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 64
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cationic trypsin
Gene (Uniprot):PRSS1
Chain IDs:A, C (auth: B), D (auth: C), E (auth: D), F (auth: E), G (auth: F)
Chain Length:223
Number of Molecules:6
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:Kunitz-type inihibitor
Mutations:L55R
Chain IDs:B (auth: G), H, I, J, K, L
Chain Length:169
Number of Molecules:6
Biological Source:Bauhinia bauhinioides
Primary Citation
Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes.
Acta Crystallogr D Struct Biol 75 56 69 (2019)
PMID: 30644845 DOI: 10.1107/S2059798318016492

Abstact

Structures of a recombinant Kunitz-type serine protease inhibitor from Bauhinia bauhinioides (BbKI) complexed with bovine trypsin were determined in two crystal forms. The crystal structure with the L55R mutant of BbKI was determined in space group P64 at 1.94 Å resolution and that with native BbKI in the monoclinic space group P21 at 3.95 Å resolution. The asymmetric unit of the latter crystals contained 44 independent complexes, thus representing one of the largest numbers of independent objects deposited in the Protein Data Bank. Additionally, the structure of the complex with native BbKI was determined at 2.0 Å resolution from P64 crystals isomorphous to those of the mutant. Since BbKI has previously been found to be a potent inhibitor of the trypsin-like plasma kallikrein, it was also tested against several tissue kallikreins. It was found that BbKI is a potent inhibitor of human tissue kallikrein 4 (KLK4) and the chymotrypsin-like human tissue kallikrein 7 (KLK7). Structures of BbKI complexed with the catalytic domain of human plasma kallikrein were modeled, as well as those with KLK4 and KLK7, and the structures were analyzed in order to identify the interactions that are responsible for inhibitory potency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures